PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 10344879

Notifying the competent authorities.

M E Donawa
View original source ↗Export metadata ↓

Abstract

The Medical Device Directive requires manufacturers or persons designated by them to provide Competent Authorities with certain types of information on some categories of medical devices. However, this requirement is often misinterpreted and there are some national variations related to the notification of Competent Authorities. This article will discuss Article 14 of the Directive, some frequent misinterpretations and, briefly, Germany's notification requirements.

Explore related subjects

Equipment and SuppliesEuropeGovernmentGuideline AdherenceHumansInformation ServicesProduct Surveillance, PostmarketingJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

M E Donawa. 1998. Notifying the competent authorities.. https://pubmed.ncbi.nlm.nih.gov/10344879/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2026

An impact assessment of the European medical device regulations implementation - the current status quo.

BACKGROUND: This research aims to assess the current impact of the medical and in-vitro diagnostic devices regulations (MDR/IVDR) on the device industry in the EU, under the lens of postimplementation and the amending regulation, and in advance of the final transition to the IVDR/MDR in the future. RESEARCH DESIGN AND METHODS: A quantitative survey was administered to a diverse cohort of medical device enterprises, ranging from micro to large organizations. RESULTS: The survey indicates that the MDR/IVDR has harmed innovation, leading many manufacturers to seek initial device approval and launch elsewhere before in Europe. There is evidence that some manufacturers have rationalized their existing product portfolios and removed devices from the market as they stated they would in previous industry surveys. The MDR/IVDR has been shown to negatively impact manufacturers, with increased costs related to notified body (NB) fees, maintaining and updating documentation, recertification fees, and hiring additional staff. CONCLUSION: This study provides a current status of the effects of MDR/IVDR on manufacturers and finds that despite amending regulations and other interventions taken by the EU to mitigate regulatory burden, ensure product availability, and address stakeholder concerns, the EU is no longer the market of choice for new products.

Equipment and Supplies↗